Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

The Lancet

Volumn 337, Issue 8752, 1991, Pages 1292-1293

  Knox, KonstanceK ^a   Drobyski, WilliamR ^a   Carrigan, DonaldR ^a  

^a Bone Marrow Transplant Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR;

ADULT; BONE MARROW TRANSPLANTATION; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; BONE TRANSPLANTATION; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; FEMALE; FOSCARNET; GANCICLOVIR; HUMAN; PHOSPHONOACETIC ACID;

EID: 0025821687     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)92965-5     Document Type: Letter

References (9)

1. Progressive disease due to ganciclovir resistant cytomegalovirus in immunocompromised patients
2. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy
3. Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro
4. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo
5. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin phosphonoformate and acyclic nucleoside triphosphates
6. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid
7. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase
8. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome